SIERRA ONCOLOGY
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
SIERRA ONCOLOGY
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2004-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.sierraoncology.com
Total Employee:
101+
Status:
Active
Contact:
(604)558-6536
Email Addresses:
[email protected]
Total Funding:
494.13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
MetronomX
MetronomX is a drug development and cancer therapeutics as well as successful entrepreneurs in marketed biologics, generics
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Sierra Oncology
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series D - Sierra Oncology
RA Capital Management
RA Capital Management investment in Series D - Sierra Oncology
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series D - Sierra Oncology
Capital Midwest Fund
Capital Midwest Fund investment in Series D - Sierra Oncology
Apjohn ventures
Apjohn ventures investment in Series D - Sierra Oncology
Vivo Capital
Vivo Capital investment in Series D - Sierra Oncology
Janus Capital Group
Janus Capital Group investment in Series D - Sierra Oncology
The Amherst Fund
The Amherst Fund investment in Series D - Sierra Oncology
OrbiMed
OrbiMed investment in Series D - Sierra Oncology
Key Employee Changes
Official Site Inspections
http://www.sierraoncology.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.71 K
- Host name: 144.236.160.34.bc.googleusercontent.com
- IP address: 34.160.236.144
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sierra Oncology"
GSK completes acquisition of Sierra Oncology
Jul 1, 2022 GSK announced it has completed the acquisition of Sierra Oncology, a California-based biopharmaceutical company.See details»
Sierra Oncology - Crunchbase Company Profile & Funding
Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.See details»
Sierra Oncology, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sierra Oncology, Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Sierra Oncology Inc Company Profile - Overview - GlobalData
Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics …See details»
Sierra Oncology 2025 Company Profile: Valuation, …
Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response …See details»
Sierra Oncology Company Profile - Office Locations, Competitors …
Sierra Oncology (formerly known as ProNAi Therapeutics) is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. Its lead …See details»
Sierra Oncology, Inc. - AnnualReports.com
Sierra Oncology is a late stage drug development company focused on achieving the successful registration and commercialization of momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated …See details»
Sierra Oncology - Ownership and Business Overview | Mergr
Apr 13, 2022 Sierra Oncology is a late-stage biopharmaceutical company based in San Mateo, California, on a mission to deliver targeted therapies that treat rare forms of cancer. Sierra …See details»
Sierra Oncology - Overview, News & Similar companies - ZoomInfo
View Sierra Oncology (www.sierraoncology.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Sierra Oncology - VentureRadar
"Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify …See details»
Sierra Oncology - Company Profile & Staff Directory | ContactOut
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify …See details»
GSK completes acquisition of Sierra Oncology
Jul 1, 2022 The acquisition was approved by Sierra Oncology's shareholders on 29 June 2022. As previously announced, the acquisition of Sierra Oncology includes momelotinib, a late …See details»
Sierra Oncology - News, Mergers and Acquisitions, Locations and ...
Usearch identified 2 signals for Sierra Oncology, including: 2 Mergers and Acquisitions. Usearch has identified 1 executive & key decision-maker.See details»
Sierra Oncology Company Overview, Contact Details
Jan 31, 2022 Learn more about Sierra Oncology's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Organization: Sierra Oncology - Cbonds.com
Sierra Oncology. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
GSK acquires US-based Sierra Oncology for $1.9bn
Jul 4, 2022 GlaxoSmithKline (GSK) has completed the acquisition of all outstanding shares of Sierra Oncology in a deal totalling $1.9bn (£1.6bn), in cash.See details»
Sierra Oncology, Inc Company Profile | Vancouver, BC, Canada ...
Find company research, competitor information, contact details & financial data for Sierra Oncology, Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Sierra Oncology - LinkedIn
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify …See details»
GlaxoSmithKline to buy Sierra Oncology for £1.5bn to boost …
Apr 13, 2022 GlaxoSmithKline has reached an agreement to buy blood cancer specialist Sierra Oncology for £1.5bn as part of plans to strengthen its drug pipeline after pressure from activist …See details»
Sierra Oncology Welcomes Two New Independent Directors to
Jun 3, 2021 Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to …See details»